The 5,000-Mile Mission: How Pat McAleer Cycled Across America to Combat Type 1 Diabetes

VIRGINIA BEACH, VA — When Pat McAleer dipped his bicycle tires into the frigid waters of the Pacific Ocean at La Push, Washington, on July 15, the road ahead was more than just a geographical challenge; it was a mission of endurance, advocacy, and hope. Three months, several mountain ranges, and more than 5,000 miles later, McAleer arrived at the shores of the Atlantic Ocean in Virginia Beach, Virginia. He didn’t just carry his gear across the continent; he carried the stories of millions living with type 1 diabetes (T1D) and a staggering $250,000 in donations intended to find a cure.

n

The initiative, dubbed "Ride Pat Ride," has become a beacon for the T1D community, highlighting the power of grassroots fundraising and the resilience of the human spirit. Supported by Breakthrough T1D (formerly JDRF), McAleer’s journey serves as a testament to what can be achieved when personal passion intersects with a global health crisis.

n

Main Facts: A Transcontinental Triumph for T1D

n

The "Ride Pat Ride" campaign was designed as a solo, unsupported transcontinental trek. Starting in mid-July, McAleer navigated a winding route that took him through the Pacific Northwest, across the Great Plains, around the Great Lakes, and down the Eastern Seaboard.

n

Key Statistics of the Journey:

n

    n

  • Total Distance: 5,000+ miles.
  • n

  • Duration: 89 days (July 15 to October 11).
  • n

  • Funds Raised: $250,000+ (surpassing the initial goal).
  • n

  • Beneficiary: Breakthrough T1D, the leading global organization funding T1D research.
  • n

  • Final Destination: The Cavalier Hotel, Virginia Beach, VA.
  • n

n

Type 1 diabetes is an autoimmune disease in which the pancreas produces little to no insulin, a hormone required to allow sugar (glucose) to enter cells to produce energy. Unlike type 2 diabetes, T1D is not related to diet or lifestyle and currently has no cure. McAleer’s fundraising is specifically earmarked for "Breakthrough" research—scientific endeavors aimed at disease-modifying therapies and, ultimately, a biological cure.

n

Chronology: From the Pacific Mist to the Atlantic Sun

n

McAleer’s journey was not a straight line, but a curated path designed to touch as many communities and landmarks as possible.

n

The Departure (July):nThe journey began in La Push, Washington. The early stages were defined by the grueling climbs of the Cascades and the unpredictable weather of the Northwest. Within the first week, McAleer faced his first major mechanical crisis—a derailleur ripped off by a stray stick just six miles into a day’s ride. This early setback tested his resolve, forcing an immediate pivot to find repairs in rural territory.

Ride Pat Ride: A Virginia Beach Finish, for T1D

n

The Heartland (August):nBy August, McAleer was traversing the vast expanses of Montana and North Dakota. This segment of the ride was characterized by "big sky" vistas and the mental solitude of solo cycling. It was here that McAleer began to realize the scale of public support. Passersby in rural towns, seeing his "Ride Pat Ride" insignias, would frequently stop to offer water, encouragement, or personal stories of how T1D had affected their families.

n

The Empire State Trail (September):nAs autumn approached, McAleer reached Buffalo, New York. Here, the "solo" nature of the ride shifted briefly. He was joined by 19 friends and fellow advocates for a group ride along the Empire State Trail, heading toward New York City. This leg served as a morale booster, transforming the solitary trek into a rolling celebration of the cause.

n

The NYC Rejuvenation (Late September):nArriving in Manhattan, McAleer and his wife, Molly, made a national appearance on the Today show, bringing the T1D mission to a domestic audience of millions. Following the media appearance, McAleer met with Aaron J. Kowalski, Ph.D., the CEO of Breakthrough T1D, at the organization’s Lower Manhattan headquarters.

n

"My conversation with Aaron just recharged my battery to finish the last two weeks of the trip strong," McAleer reflected. "I didn’t know that’s what I was looking for, but that ended up being what I needed at the time."

n

The Final Push (October):nLeaving New York via the Staten Island Ferry, McAleer pedaled through New Jersey, Pennsylvania, and Maryland. He made a sentimental stop at his mother’s home in Fairfax, Virginia, and his alma mater, the University of Mary Washington in Fredericksburg. The final week was plagued by a hurricane moving up the coast, forcing McAleer to abandon camping in favor of hotels to avoid falling limbs and high winds. On October 11, he reached the Cavalier Hotel in Virginia Beach, greeted by a crowd of supporters and the news that his fundraising had officially crossed the quarter-million-dollar mark.

n

Supporting Data: The Logistics of Endurance

n

The success of "Ride Pat Ride" was built on a foundation of meticulous planning and physical preparation. Cycling 5,000 miles requires a caloric intake often exceeding 4,000 to 6,000 calories per day to maintain muscle mass and energy levels.

n

McAleer utilized the "Breakthrough T1D Your Way" platform, a DIY fundraising tool that allows individuals to create custom campaigns. This platform provided the digital infrastructure to process thousands of small-dollar donations that eventually aggregated into the $250,000 total.

n

Physical Toll and Recovery:
The physical demands were immense. Upon completing the ride, McAleer reported sleeping for 11 consecutive hours, followed by three naps the following day. "Physically, the body just tells you when it’s done," McAleer said. "I don’t normally nap, but after 5,000 miles, your internal clock demands a reset."

Ride Pat Ride: A Virginia Beach Finish, for T1D

Official Responses: Leadership and Advocacy

The leadership at Breakthrough T1D has hailed McAleer’s ride as a premier example of "adventure philanthropy."

CEO Aaron J. Kowalski emphasized the importance of such individual efforts: "Pat’s journey is a powerful metaphor for the T1D experience. It’s long, it’s grueling, and there are unexpected obstacles, but with persistence and community support, we move forward. The funds he raised are going directly into the hands of the world’s best scientists."

McAleer’s own reflections focused less on his physical feat and more on the human connections made along the way. "The takeaway for me was a self-assessment. A lot of people looked out for me on the side of the road in Montana or Maryland. It made me ask: Am I doing that enough for others?"

He also noted the unpredictability of the journey. "The things that go according to plan rarely make the highlight reel. It’s the things that don’t go right—the curveballs—that test your strength and make the story worth telling."

Implications: The Future of T1D Research and Community Action

The $250,000 raised by McAleer comes at a pivotal time for T1D research. Breakthrough T1D is currently funneling resources into several high-priority areas:

  1. Cell Therapies: Replacing insulin-producing cells that the immune system has destroyed.
  2. Disease-Modifying Therapies: Developing treatments to slow or stop the progression of T1D in those newly diagnosed.
  3. Universal Screening: Identifying individuals at risk before they develop life-threatening ketoacidosis.

McAleer’s success has also spurred a surge in interest in the "Breakthrough T1D Your Way" program. By demonstrating that a single individual can raise a significant sum through a personal challenge, he has provided a blueprint for other advocates. For those who cannot commit to a three-month trek, the organization promotes "Breakthrough T1D Ride," which offers shorter, organized cycling events in five destinations across the U.S., as well as the "My Ride" virtual program.

As Pat McAleer returns to his home in Richmond, his journey leaves a lasting impact on the T1D landscape. He proved that while the road to a cure is long—perhaps even longer than 5,000 miles—it is a distance that can be covered, one pedal stroke at a time.


About Breakthrough T1D:
Breakthrough T1D (formerly JDRF) is the leading global organization funding type 1 diabetes (T1D) research. Its mission is to accelerate life-changing breakthroughs to cure, prevent, and treat T1D and its complications. To learn more or to start your own "Your Way" campaign, visit breakthrought1d.org.

Lyrica Pills
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.